Cehelsky, Jeffrey E.
University of Auckland · St George's, University of London · The Royal Free Hospital · Auckland City Hospital · Intellia Therapeutics (United States) · University College London
2 papers on CoChat
Most cited papers
- Verified
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
Gillmore, J. D., Gane, E., Taubel, J., Kao, J., Fontana, M., Maitland, M. L., Seitzer, J., O’Connell, D., Walsh, K. R., Wood, K., et al. (2021) · New England Journal of Medicine
Amyloidosis: Diagnosis, Treatment, OutcomesCRISPR and Genetic Engineering
Cited by 1,801
- Verified
Safety and efficacy of RNAi therapy for transthyretin amyloidosis
Coelho, T., Adams, D., Silva, A., Lozeron, P., Hawkins, P. N., Mant, T., Perez, J., Chiesa, J., Warrington, S., Tranter, E., et al. (2013) · New England Journal of Medicine
Amyloidosis: Diagnosis, Treatment, OutcomesRNA Interference and Gene Delivery
Cited by 971
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free